LBO1 DORIS remission in patients with SLE treated with anifrolumab or placebo during the 4-year TULIP-LTE trial: post hoc analysis - Richard Furie; Raj Tummala; Kenneth Kalunian; Eric Morand; Gabriel Abreu; Ronald van Vollenhoven; Catharina Lindholm; Hussein Al-Mossawi (Lupus Science and Medicine, 2024)